Trial Summary
What is the purpose of this trial?
The goal of this study is to investigate the effectiveness of stand-alone air filtration for improving indoor air quality (IAQ) and chronic obstructive pulmonary disease (COPD) outcomes in a high-risk urban cohort of 80 U.S. military veterans with COPD. Secondary goals of the study are to (1) investigate housing-related factors that may contribute to COPD exacerbation, (2) investigate the utility of using low-cost sensors for indoor air pollution epidemiology studies and for providing actionable or useful information on the quality of their indoor air to patients and their physicians, and (3) evaluate the costs and benefits of using stand-alone air filtration to improve IAQ and COPD outcomes.
Research Team
Kaveeta Jagota
Principal Investigator
Jesse Brown VA Medical Center
Israel Rubinstein, MD
Principal Investigator
Jesse Brown VA Medical Center
Mohammad Heidarinejad, PhD
Principal Investigator
Illinois Institute of Technology
Zane Elfessi, PharmD
Principal Investigator
Jesse Brown VA Medical Center
Eligibility Criteria
This trial is for U.S. military veterans aged 18 and older who have COPD, live in Chicago, can consent, speak English, have stable housing for over 6 months, can communicate by phone, are fully vaccinated against COVID-19 and receive care at JBVAMC. Those with a life expectancy under 6 months or hazardous home conditions cannot join.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- Air cleaner (Other)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Illinois Institute of Technology
Lead Sponsor
Elevate
Collaborator
Jesse Brown VA Medical Center
Collaborator
US Department of Housing and Urban Development
Collaborator